Impedancemetry in Patients Monitored for Pulmonary Hypertension (HPepic)
Prognostic Value of Cardiac Output Measured by Impedancemetry in Patients Monitored for Pulmonary Hypertension
Sponsor: University Hospital, Toulouse
Terminated
RECRUITMENT ISSUES
Other terminated trials from University Hospital, Toulouse
Other Pulmonary Hypertension trials with similar outcome
A NA clinical study on Pulmonary Hypertension, this trial is terminated or withdrawn. The trial is conducted by University Hospital, Toulouse and has accumulated 9 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Aug 2023 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jul 2022 — Aug 2023 [monthly]
Recruiting NA
-
Nov 2021 — Jul 2022 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Oct 2020 — Dec 2020 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Oct 2018 — Oct 2020 [monthly]
Recruiting NA
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Toulouse
For direct contact, visit the study record on ClinicalTrials.gov .